Caption Management, LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $6.86 Million - $11.8 Million	-47,900 Reduced 14.48%	283,000 $68.8 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $39.1 Million - $52.9 Million	266,900 Added 417.03%	330,900 $49.5 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $7.51 Million - $9.75 Million	-49,600 Reduced 43.66%	64,000 $12.3 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $16.4 Million - $18.8 Million	88,600 Added 354.4%	113,600 $21.6 Million
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $4.64 Million - $6.03 Million	-25,000 Reduced 50.0%	25,000 $5.94 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $46.8 Million - $78.3 Million	-337,500 Reduced 87.1%	50,000 $10 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $43.1 Million - $60.5 Million	357,500 Added 1191.67%	387,500 $56.5 Million
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $10.4 Million - $14.2 Million	-81,500 Reduced 73.09%	30,000 $4.9 Million
Q4 2021 Feb 11, 2022	BUY	$159.56 - $209.29 $13 Million - $17.1 Million	81,500 Added 271.67%	111,500 $18.9 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $19 Million - $23.3 Million	-112,100 Reduced 78.89%	30,000 $5.66 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $11.8 Million - $16.3 Million	92,100 Added 184.2%	142,100 $24.1 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $23.1 Million - $32 Million	-182,000 Reduced 78.45%	50,000 $7.06 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $26.1 Million - $31.2 Million	212,000 Added 1060.0%	232,000 $30.2 Million
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $2.42 Million - $3.31 Million	20,000 New	20,000 $2.91 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $2.58 Million - $3.2 Million	-36,400 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$65.86 - $92.79 $2.4 Million - $3.38 Million	36,400 New	36,400 $2.64 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.07 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.12 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.35 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.29 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.22 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account